DreaMed Diabetes, the Petah Tikva-based developer of personalized diabetes management solutions, has received US Food and Drug Administration (FDA) clearance for its artificial intelligence-powered insulin recommendations technology.
Read more here.
DreaMed Diabetes, the Petah Tikva-based developer of personalized diabetes management solutions, has received US Food and Drug Administration (FDA) clearance for its artificial intelligence-powered insulin recommendations technology.
Read more here.
![[Tala in TechCrunch] With loans of just $10, this startup has built a financial services powerhouse in emerging markets](https://blog.mktg.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
